Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 19

1.

Synthesis and antibacterial activity of dihydro-1,2-oxazine and 2-pyrazoline oxazolidinones: novel analogs of linezolid.

D'Andrea S, Zheng ZB, Denbleyker K, Fung-Tomc JC, Yang H, Clark J, Taylor D, Bronson J.

Bioorg Med Chem Lett. 2005 Jun 2;15(11):2834-9.

PMID:
15911264
2.

Antimicrobial evaluation of nocathiacins, a thiazole peptide class of antibiotics.

Pucci MJ, Bronson JJ, Barrett JF, DenBleyker KL, Discotto LF, Fung-Tomc JC, Ueda Y.

Antimicrob Agents Chemother. 2004 Oct;48(10):3697-701.

3.

Discovery of isoxazolinone antibacterial agents. Nitrogen as a replacement for the stereogenic center found in oxazolidinone antibacterials.

Snyder LB, Meng Z, Mate R, D'Andrea SV, Marinier A, Quesnelle CA, Gill P, DenBleyker KL, Fung-Tomc JC, Frosco M, Martel A, Barrett JF, Bronson JJ.

Bioorg Med Chem Lett. 2004 Sep 20;14(18):4735-9.

PMID:
15324898
4.
5.

In vitro and in vivo activities of a novel cephalosporin, BMS-247243, against organisms other than staphylococci.

Clark J, Fung-Tomc JC, Minassian B, Tsai YH, Yang H, Huczko E, Kolek B, Chaniewski S, Ferraro C, Drain R, Gradelski E, Bonner DP.

Antimicrob Agents Chemother. 2002 Apr;46(4):1108-11.

6.

In vitro and in vivo activities of a novel cephalosporin, BMS-247243, against methicillin-resistant and -susceptible staphylococci.

Fung-Tomc JC, Clark J, Minassian B, Pucci M, Tsai YH, Gradelski E, Lamb L, Medina I, Huczko E, Kolek B, Chaniewski S, Ferraro C, Washo T, Bonner DP.

Antimicrob Agents Chemother. 2002 Apr;46(4):971-6.

7.

Antibacterial spectrum of a novel des-fluoro(6) quinolone, BMS-284756.

Fung-Tomc JC, Minassian B, Kolek B, Huczko E, Aleksunes L, Stickle T, Washo T, Gradelski E, Valera L, Bonner DP.

Antimicrob Agents Chemother. 2000 Dec;44(12):3351-6.

8.

Comparative killing rates of fluoroquinolones and cell wall-active agents.

Fung-Tomc JC, Gradelski E, Valera L, Kolek B, Bonner DP.

Antimicrob Agents Chemother. 2000 May;44(5):1377-80.

9.

In vitro antifungal activity of BMS-207147 and itraconazole against yeast strains that are non-susceptible to fluconazole.

Fung-Tomc JC, White TC, Minassian B, Huczko E, Bonner DP.

Diagn Microbiol Infect Dis. 1999 Oct;35(2):163-7.

PMID:
10579098
10.

In vitro activity of a new oral triazole, BMS-207147 (ER-30346)

Fung-Tomc JC, Huczko E, Minassian B, Bonner DP.

Antimicrob Agents Chemother. 1998 Feb;42(2):313-8. Erratum in: Antimicrob Agents Chemother 1998 Apr;42(4):993.

11.

Recent developments in pradimicin-benanomicin and triazole antibiotics.

Fung-Tomc JC, Bonner DP.

Expert Opin Investig Drugs. 1997 Feb;6(2):129-45.

PMID:
15989596
12.

Differences in the resistant variants of Enterobacter cloacae selected by extended-spectrum cephalosporins.

Fung-Tomc JC, Gradelski E, Huczko E, Dougherty TJ, Kessler RE, Bonner DP.

Antimicrob Agents Chemother. 1996 May;40(5):1289-93.

13.

Antibacterial activities of cefprozil compared with those of 13 oral cephems and 3 macrolides.

Fung-Tomc JC, Huczko E, Stickle T, Minassian B, Kolek B, Denbleyker K, Bonner D, Kessler R.

Antimicrob Agents Chemother. 1995 Feb;39(2):533-8.

14.

Structure-activity relationships of carbapenems that determine their dependence on porin protein D2 for activity against Pseudomonas aeruginosa.

Fung-Tomc JC, Huczko E, Banville J, Ménard M, Kolek B, Gradelski E, Kessler RE, Bonner DP.

Antimicrob Agents Chemother. 1995 Feb;39(2):394-9.

15.

Activity of carbapenem BMS-181139 against Pseudomonas aeruginosa is not dependent on porin protein D2.

Fung-Tomc JC, Gradelski E, Kolek B, Minassian B, Pucci M, Kessler RE, Bonner DP.

Antimicrob Agents Chemother. 1995 Feb;39(2):386-93.

16.

In vitro antifungal and fungicidal spectra of a new pradimicin derivative, BMS-181184.

Fung-Tomc JC, Minassian B, Huczko E, Kolek B, Bonner DP, Kessler RE.

Antimicrob Agents Chemother. 1995 Feb;39(2):295-300.

17.

Susceptibility of United States clinical trial isolates to cefprozil and cefaclor.

Kessler RE, Fung-Tomc JC.

Diagn Microbiol Infect Dis. 1994 Feb;18(2):129-32.

PMID:
8062532
19.

Comparison of the inhibitory and bactericidal activity of aztreonam and amikacin against gram negative aerobic bacilli.

Fung-Tomc JC, Lincourt W, Thater C, Kessler RE.

Ann Clin Lab Sci. 1988 Nov-Dec;18(6):463-7.

PMID:
3239949

Supplemental Content

Loading ...
Support Center